Answers are grounded in this paper and cite their sources.
Drug repurposing is a convenient alternative when the need for new drugs in an unexpected medical scenario is urgent, as is the case of emerging pathogens. In recent years, approaches based on network biology have demonstrated to be superior to gene-centric ones. 1 Here, we use an innovative methodology that combines mechanistic modeling of the signal transduction circuits related to SARS-CoV-2 infection (the COVID-19 disease map) with a machine-learning algorithm that learns potential causal interactions between proteins, already targets of drugs, and specific signaling circuits in the COVID-19 disease map, to suggest potentially repurposable drugs.
No takes yet. Share an insight, caveat, or question.
Loucera et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: